FDA Approves Two Hepatitis C Drugs for Pediatric Patients
Silver Spring, Maryland–(ENEWSPF)–April 7, 2017. The U.S. Food and Drug Administration today approved supplemental applications for Sovaldi (sofosbuvir) and Harvoni (ledipasvir and … Read more